CVE-2024-0758: Ipb-Halle Molecularfaces

Medium severity, CVSS 6.1. EPSS: 0.6% chance of exploitation in the next 30 days.

MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.

Affected products

• Ipb-Halle Molecularfaces: before 0.3.0 (fixed in 0.3.0)

Published 2024-01-19. Last modified 2026-07-14.